Treatment of Staph Wounds
Yes, you should treat a staph wound with antibiotics, but the specific approach depends critically on whether the infection is purulent (abscess/boil) or nonpurulent (cellulitis), and whether MRSA is suspected. For purulent infections, incision and drainage is mandatory and often sufficient alone for small abscesses, while antibiotics are reserved for specific indications. For nonpurulent cellulitis, antibiotics targeting streptococci and methicillin-susceptible staph are first-line.
Initial Assessment: Purulent vs. Nonpurulent
The single most important clinical decision is determining whether the wound is purulent or nonpurulent, as this fundamentally changes management. 1
Purulent Infections (Abscesses, Furuncles, Carbuncles)
- Incision and drainage is the primary treatment and is mandatory for any abscess or purulent collection 1, 2
- Obtain cultures from purulent drainage before starting antibiotics to confirm the pathogen and guide therapy 1, 3, 2
- Antibiotics are adjunctive and indicated only when specific criteria are met 1, 2
Nonpurulent Infections (Cellulitis, Wound Infections)
- Antibiotics are the primary treatment 1
- Surgical debridement is required for deeper soft-tissue infections, surgical/traumatic wound infections, and major abscesses 1
When to Add Antibiotics for Purulent Staph Infections
Do not reflexively prescribe antibiotics for every abscess—incision and drainage alone is often sufficient. 1 Add antibiotics only when:
- Systemic inflammatory response syndrome (SIRS) present: fever >38°C or <36°C, tachycardia >90 bpm, tachypnea >24 breaths/min, or WBC >12,000 or <4,000 cells/µL 1, 2
- Severe or extensive disease involving multiple sites 2
- Rapid progression with associated cellulitis 2
- Immunosuppression or comorbidities (diabetes, HIV, malignancy, neutropenia) 2, 1
- Extremes of age 2
- Difficult-to-drain locations (face, hand, genitalia) 2
- Lack of response to drainage alone 2
- Erythema extending >5 cm beyond wound margins 1
Antibiotic Selection Algorithm
For Methicillin-Susceptible Staph aureus (MSSA)
First-line oral therapy:
- Dicloxacillin 250-500 mg every 6 hours for 5-7 days 3, 4, 5
- Cephalexin 500 mg four times daily for 5-7 days 3, 4, 6
Alternative oral options:
- Cefadroxil or cefprozil (once-daily dosing, better tolerability but more expensive) 6
- Clindamycin 300-450 mg three times daily (covers both MSSA and streptococci) 1, 3
Intravenous options for hospitalized patients:
- Cefazolin 1-2 g IV every 8 hours (preferred IV beta-lactam) 1, 7
- Nafcillin or oxacillin 2 g IV every 6 hours 1, 5
For Methicillin-Resistant Staph aureus (MRSA)
First-line oral therapy:
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets (160/800 mg) twice daily for 7-10 days 3, 2, 4
- Doxycycline 100 mg twice daily for 7-10 days 3, 2, 4
- Clindamycin 300-450 mg three times daily for 7-10 days (only if local resistance <10%) 1, 3, 2
Intravenous options for hospitalized patients:
- Vancomycin 15-20 mg/kg IV every 8-12 hours (first-line, A-I evidence) 1, 7
- Linezolid 600 mg IV twice daily (A-I evidence) 1, 7, 8, 9
- Daptomycin 4 mg/kg IV once daily (A-I evidence) 1, 7
- Telavancin 10 mg/kg IV once daily (A-I evidence) 1
For Complicated/Deep Wound Infections
For deeper soft-tissue infections, surgical/traumatic wounds, or major abscesses requiring hospitalization:
- Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS surgical debridement 1
- Alternative: Linezolid 600 mg IV twice daily 1
- Alternative: Daptomycin 4 mg/kg IV once daily 1
- Alternative: Clindamycin 600 mg IV three times daily (if local resistance <10%) 1
Treatment Duration
Treat for 5-7 days if clinical improvement occurs; extend only if symptoms have not improved within this timeframe 1, 7, 3, 10
- For uncomplicated purulent infections: 5-7 days 3, 10
- For complicated skin and soft tissue infections: 7-14 days individualized based on clinical response 1
- For severe infections with systemic toxicity: 7-14 days 1
Critical Caveats and Common Pitfalls
Avoid These Mistakes:
- Do not use doxycycline or TMP-SMX as monotherapy for typical cellulitis without purulent drainage, as their activity against beta-hemolytic streptococci is unreliable 7, 2
- Do not add MRSA coverage reflexively for every staph wound—MRSA is uncommon in typical nonpurulent cellulitis even in high-prevalence settings 1, 7
- Do not prescribe antibiotics for simple abscesses without the indications listed above—incision and drainage alone is often sufficient 1
- Do not use clindamycin if local MRSA resistance rates are >10%—choose TMP-SMX or doxycycline instead 1, 2
- Do not use tetracyclines (doxycycline) in children <8 years of age due to tooth discoloration 1, 3
Special Populations:
Pediatric dosing for MRSA:
- Clindamycin 10-13 mg/kg/dose IV every 6-8 hours (hospitalized children) 1, 3
- Linezolid 600 mg IV twice daily for children >12 years, or 10 mg/kg/dose IV every 8 hours for children <12 years 1
Penicillin-allergic patients:
- Clindamycin 300-450 mg three times daily (covers both MSSA and MRSA) 7, 3
- Avoid cephalosporins in patients with immediate-type penicillin hypersensitivity (urticaria, angioedema, bronchospasm, anaphylaxis) 4
Adjunctive Wound Care Measures
Proper wound management is as important as antibiotic selection:
- Keep draining wounds covered with clean, dry bandages 1
- Maintain good personal hygiene with regular bathing and hand washing with soap and water or alcohol-based gel 1
- Avoid reusing or sharing personal items (razors, linens, towels) that contacted infected skin 1
- Elevate affected extremities to promote drainage 7
- Debride necrotic tissue and remove foreign bodies 1, 6
When to Hospitalize
Admit patients with any of the following:
- Systemic inflammatory response syndrome (SIRS) 1, 7
- Hypotension or hemodynamic instability 7
- Altered mental status or confusion 7
- Severe immunocompromise or neutropenia 7
- Concern for necrotizing infection (severe pain out of proportion to exam, rapid progression, gas in tissue, skin anesthesia, bullous changes) 1, 7
For suspected necrotizing fasciitis, obtain emergent surgical consultation and initiate broad-spectrum combination therapy immediately with vancomycin or linezolid PLUS piperacillin-tazobactam, a carbapenem, or ceftriaxone plus metronidazole 1, 7